Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IX0N
|
||||
Former ID |
DNC011569
|
||||
Drug Name |
N*1*-(5-Methyl-2-nitro-phenyl)-butane-1,4-diamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534663] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H17N3O2
|
||||
Canonical SMILES |
CC1=CC(=C(C=C1)[N+](=O)[O-])NCCCCN
|
||||
InChI |
1S/C11H17N3O2/c1-9-4-5-11(14(15)16)10(8-9)13-7-3-2-6-12/h4-5,8,13H,2-3,6-7,12H2,1H3
|
||||
InChIKey |
ANIBJVLRYPKMKX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric-oxide synthase, brain | Target Info | Inhibitor | [534663] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arginine and Proline Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.